Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
YAMAZAKI, 17% Decrease in Ordinary Profit for The Current Fiscal Year
6147 YAMAZAKI CO., LTD. 【J-GAAP】
Earnings ReportYAMAZAKI CO., LTD. <6147> [TSE Std] announced its financial results after the market closed on May 9th (16:00). The consolidated ordinary profit/loss for the fiscal year ending March 2025 turned into a profit of 84 million yen (compared to a loss of 86 million yen in the previous period). For the fiscal year ending March 2026, the consolidated ordinary profit is expected to decrease by 16.7% from the previous period to 70 million yen.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit increased 40.0% from the same period last year, reaching 7 million yen. However, the operating profit margin worsened from 1.7% in the same period last year to 0.1%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 2,655 | -228 | -213 | -111 | -25.1 | 10 | May 12, 2023 | J-GAAP |
| Mar, 2024 | 2,496 | -97 | -86 | -33 | -7.4 | 10 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 3,093 | 77 | 84 | 57 | 12.9 | 10 | May 9, 2025 | J-GAAP |
| YoY | +23.9% | - | - | - | - |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 3,100 | 80 | 70 | 50 | 11.3 | 10 | Nov 8, 2024 | J-GAAP |
| Mar, 2025 Results | 3,093 | 77 | 84 | 57 | 12.9 | 10 | May 9, 2025 | J-GAAP |
| Revision Rate | -0.2% | -3.8% | +20.0% | +14.0% | +14.6% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 1,565 | 56 | 53 | 37 | 8.4 | 0 | Nov 8, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 1,250 | 1 | 6 | 2 | 0.5 | 0 | May 9, 2025 | J-GAAP |
| YoY | -20.1% | -98.2% | -88.7% | -94.6% | -94.6% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 2,496 | -97 | -86 | -33 | -7.4 | 10 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 3,093 | 77 | 84 | 57 | 12.9 | 10 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 3,000 | 65 | 70 | 55 | 12.4 | 10 | May 9, 2025 | J-GAAP |
| YoY | -3.0% | -15.6% | -16.7% | -3.5% | -4.0% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 746 | 13 | 5 | 43 | 9.7 | 1.7 | May 10, 2024 | J-GAAP |
| Apr - Jun, 2024 | 645 | 0 | 7 | -1 | -0.3 | 0.0 | Aug 9, 2024 | J-GAAP |
| Jul - Sep, 2024 | 920 | 56 | 46 | 38 | 8.6 | 6.1 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 725 | 20 | 24 | 22 | 5.0 | 2.8 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 803 | 1 | 7 | -2 | -0.5 | 0.1 | May 9, 2025 | J-GAAP |
| YoY | +7.6% | -92.3% | +40.0% | - | - |
Related Articles
J-MAX, Returning to Profitability This Year
TB GROUP, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
HOKKAIDO COCACOLA, Jan-Mar (1Q) Ordinary Profit Increases by 53%
SUN-WA TECHNOS, 1% Decrease in Ordinary Profit for The Current Fiscal Year
NICHIMO, 3% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 7 yen, This Fiscal Year to Increase Dividend by 3 yen
SANKO, 39% Decrease in Ordinary Profit for The Current Fiscal Year
NAKAYO, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.
Carna Biosciences, Jan-Mar (1Q) Ordinary Profit Loss Widens
KAWADEN, 3% Decrease in Ordinary Profit for The Current Fiscal Year
Furubayashi Shiko, Jan-Mar (1Q) Ordinary Profit Turns to Profit